← Evidence map

ArticleNature2023

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.

Rodabe N Amaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36894629